Publication of Final Terms

Santander UK Plc
23 February 2024
 

SANTANDER UK PLC
€35 BILLION GLOBAL COVERED BOND PROGRAMME
Publication of Final Terms - Series 85

The following final terms (the Final Terms) are available for viewing:

Issue of Series 85 CHF 310,000,000 Fixed Rate Covered Bonds due 12 November 2028 (ISIN CH1325807878) under the €35 billion Global Covered Bond Programme of Santander UK plc (the Programme).

To view the full Final Terms document, please click on or paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/3301E_1-2024-2-23.pdf

A copy of the above Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

The Final Terms can also be viewed at: https://www.santander.co.uk/uk/about-santander-uk/debt-investors/santander-uk-covered-bonds.

Please see Annex 1 to this notice for additional information in relation to the Series 85 Covered Bonds.

For further information, please contact:

Medium Term Funding
Santander UK plc
2 Triton Square
Regent's Place
London NW1 3AN

Email: mtf@santander.co.uk

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Final Terms, the base prospectus published in respect of the Programme on 6 March 2023 as supplemented on 25 April 2023, 5 July 2023, 26 July 2023, 14 August 2023, 25 October 2023 and 31 January 2024 (the Prospectus) and the Swiss prospectus dated 21 February 2024 (the Swiss Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries only (as further specified in the Prospectus and the Swiss Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms, the Prospectus and the Swiss Prospectus is not addressed. Prior to relying on the information contained in the Final Terms, the Prospectus and the Swiss Prospectus you must ascertain from the Final Terms, the Prospectus and the Swiss Prospectus whether or not you are part of the intended addressees of the information contained therein. Your right to access this service is conditional upon complying with the above requirement.

ANNEX 1

ADDITIONAL INFORMATION IN RELATION TO SERIES 85 CHF 310,000,000 FIXED RATE COVERED BONDS DUE 12 NOVEMBER 2028

OPERATIONAL INFORMATION DOCUMENT

This Operational Information Document related to the Final Terms dated 21 February 2024 (the Final Terms) in respect of the issue of Series 85 CHF 310,000,000 Fixed Rate Covered Bonds due 12 November 2028 (ISIN CH1325807878).

This Operational Information Document has not been reviewed or approved by any competent authority for the purposes of the UK Prospectus Regulation or otherwise and does not form part of the Final Terms for the purposes of the UK Prospectus Regulation. However, for all other purposes this Operational Information Document must be read in conjunction with the Final Terms. Words and expressions which have a defined meaning in the Final Terms, the Prospectus dated 6 March 2023 as supplemented on 25 April 2023, 5 July 2023, 26 July 2023, 14 August 2023, 25 October 2023 and 31 January 2024 or the Swiss Prospectus have the same meanings in this Operational Information Document.

DISTRIBUTION

(a) If syndicated, names of Managers:                           UBS AG (the Bookrunner); and

                                                                                       Basler Kantonalbank (the Manager)

(together the Managers)

 

(b) Date of Subscription Agreement:                             21 February 2024

(c) If not syndicated, name of relevant Dealer:               Not applicable

(d) U.S. Selling Restrictions:                                        Regulation S Compliance Category 2. TEFRA D applicable (in accordance with Swiss market practice)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100